VINCOV-19, an antidote, and a cure against COVID-19, successfully completes Phase 2 Clinical Trials Kumar Jeetendra | October 13, 2022 VINS Bioproducts Limited, a leading immunological company, based in Hyderabad, in collaboration with the Centre for Cellular and Molecular Biology (CCMB) and the University of Hyderabad (UoH), announced the successful completion of Phase 2 Clinical Trials of VINCOV-19, India’s first antidote and a cure against SARS-CoV-2 virus. VINCOV-19 is now ready for market authorization and …
